Drug · DIN 02552787
MICRO+6 REGULAR
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since May 30, 2025; first marketed May 30, 2025.
- Drug Identification Number (DIN)
- 02552787
- Company (DIN owner)
- Sandoz Canada Inc.Saint-Hubert, Quebec, Canada
- Schedule
- Ethical
- Dosage form
- Solution
- Route
- Intravenous
- Therapeutic class (ATC)
- Electrolytes in comb with other drugs B05XA31
- Class
- Human
- Record last updated
- June 10, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| ZINC (ZINC SULFATE) | 1 MG | ML |
| COPPER (CUPRIC SULFATE) | 60 MCG | ML |
| MANGANESE (MANGANESE SULFATE) | 11 MCG | ML |
| CHROMIUM (CHROMIC CHLORIDE) | 2 MCG | ML |
| SELENIUM (SELENIUM OXIDE) | 12 MCG | ML |
| IODINE (SODIUM IODIDE) | 15 MCG | ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- November 13, 2024: NOC 34373Supplement to a New Drug Submission (SNDS) · Addition of new strength. Change in the composition of a dosage form. Addition of a primary container closure system